scholarly article | Q13442814 |
P50 | author | Martin Tollinger | Q42318754 |
Michael J Ausserlechner | Q64683337 | ||
Stefan Salcher | Q85643709 | ||
Sebastian Führer | Q88830343 | ||
Gilles A Spoden | Q115513030 | ||
P2093 | author name string | Thomas Müller | |
Thomas Gruber | |||
Daniela Schuster | |||
Ronald Gust | |||
Ursula Kiechl-Kohlendorfer | |||
Heinz Zwierzina | |||
Teresa Kaserer | |||
Judith Hagenbuchner | |||
Petra Obexer | |||
Petra Huber-Cantonati | |||
P2860 | cites work | AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1 | Q22254000 |
11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics | Q24564713 | ||
Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease | Q27334874 | ||
Crystal structure of the human FOXO3a-DBD/DNA complex suggests the effects of post-translational modification | Q27648799 | ||
Gene structure alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim | Q28201672 | ||
Development and validation of a genetic algorithm for flexible docking | Q28236574 | ||
FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells | Q28255883 | ||
Both the N-terminal loop and wing W2 of the forkhead domain of transcription factor Foxo4 are important for DNA binding | Q28284616 | ||
Cdk5-FOXO3a axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models | Q28396052 | ||
Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer | Q28475229 | ||
De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease | Q28568220 | ||
LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters | Q31143138 | ||
Automatic telomere length measurements in interphase nuclei by IQ-FISH. | Q33225268 | ||
A homogenous luminescent proximity assay for 14-3-3 interactions with both phosphorylated and nonphosphorylated client peptides | Q33531826 | ||
C10ORF10/DEPP-mediated ROS accumulation is a critical modulator of FOXO3-induced autophagy | Q33730108 | ||
Involvement of the PTEN-AKT-FOXO3a pathway in neuronal apoptosis in developing rat brain after hypoxia-ischemia. | Q33757441 | ||
Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells | Q33979948 | ||
The neuroprotective effect of Klotho is mediated via regulation of members of the redox system | Q34107408 | ||
Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice | Q34132966 | ||
AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias | Q34212654 | ||
Serum carbenoxolone in patients with gastric and duodenal ulcer: Absorption, efficacy and side-effects | Q34474213 | ||
The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors | Q34806728 | ||
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia | Q35441406 | ||
Forkhead box O-1 modulation improves endothelial insulin resistance in human obesity | Q35613380 | ||
Retracted: Involvement of the JNK/FOXO3a/Bim Pathway in Neuronal Apoptosis after Hypoxic-Ischemic Brain Damage in Neonatal Rats | Q35690489 | ||
Connexin and pannexin channels in cancer. | Q36031173 | ||
Targeting FoxO1 with AS1842856 suppresses adipogenesis | Q36183882 | ||
FOXO1 inhibits osteoclastogenesis partially by antagnozing MYC. | Q36280893 | ||
An Epigenetic Pathway Regulates Sensitivity of Breast Cancer Cells to HER2 Inhibition via FOXO/c-Myc Axis | Q36566350 | ||
Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells. | Q36906210 | ||
11β-hydroxysteroid dehydrogenase inhibition as a new potential therapeutic target for alcohol abuse | Q36915489 | ||
Carbenoxolone enhances TRAIL-induced apoptosis through the upregulation of death receptor 5 and inhibition of gap junction intercellular communication in human glioma. | Q36936884 | ||
Regulation of forkhead transcription factor FoxO3a contributes to calorie restriction-induced prevention of Alzheimer's disease-type amyloid neuropathology and spatial memory deterioration | Q37020746 | ||
Forkhead transcription factors: new considerations for alzheimer's disease and dementia | Q37064987 | ||
Structure/function relationships underlying regulation of FOXO transcription factors | Q37129790 | ||
FOXO3a promotes tumor cell invasion through the induction of matrix metalloproteinases. | Q37334058 | ||
FoxO3a confers cetuximab resistance in RAS wild-type metastatic colorectal cancer through c-Myc | Q37697088 | ||
Nuclear FOXO3 predicts adverse clinical outcome and promotes tumor angiogenesis in neuroblastoma. | Q37718408 | ||
Novel therapeutic approach to eradicate tyrosine kinase inhibitor resistant chronic myeloid leukemia stem cells | Q37759021 | ||
Structural basis for DNA recognition by FOXO proteins | Q37819155 | ||
The use of connexin-based therapeutic approaches to target inflammatory diseases. | Q38136917 | ||
Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells | Q38292631 | ||
FOXO transcription factors in cancer development and therapy | Q38674456 | ||
The FOXO3/PGC-1β signaling axis is essential for cancer stem cell properties of pancreatic ductal adenocarcinoma | Q38703418 | ||
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging | Q38710688 | ||
AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction. | Q38712894 | ||
FoxO3a induces temozolomide resistance in glioblastoma cells via the regulation of β-catenin nuclear accumulation | Q38713756 | ||
Mitochondrial FOXO3a is involved in amyloid β peptide-induced mitochondrial dysfunction | Q38802040 | ||
FOXP1 acts through a negative feedback loop to suppress FOXO-induced apoptosis | Q39129282 | ||
FOXO3 is essential for CD44 expression in pancreatic cancer cells. | Q39148508 | ||
β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer | Q39345531 | ||
Pharmacology of the treatment of peptic ulcer disease | Q39398670 | ||
TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia | Q39744014 | ||
The forkhead transcription factor FOXO3a increases phosphoinositide-3 kinase/Akt activity in drug-resistant leukemic cells through induction of PIK3CA expression | Q39958777 | ||
Activation of Akt predicts poor outcome in neuroblastoma | Q40181645 | ||
A member of Forkhead transcription factor FKHRL1 is a downstream effector of STI571-induced cell cycle arrest in BCR-ABL-expressing cells | Q40686902 | ||
High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein | Q41072145 | ||
Three-dimensional tumor cell growth stimulates autophagic flux and recapitulates chemotherapy resistance | Q41168233 | ||
Differentiation-related expression of adhesion molecules and receptors on human neuroblastoma tissues, cell lines and variants | Q41607949 | ||
Carbenoxolone induces apoptosis and inhibits survivin and survivin-ΔEx3 genes expression in human leukemia K562 cells | Q42323641 | ||
C10ORF10/DEPP, a transcriptional target of FOXO3, regulates ROS-sensitivity in human neuroblastoma. | Q42944478 | ||
FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3. | Q43816387 | ||
IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells | Q44536385 | ||
Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization. | Q45027288 | ||
FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3. | Q45100601 | ||
Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension | Q45869636 | ||
Suppression of FoxO3a attenuates neurobehavioral deficits after traumatic brain injury through inhibiting neuronal autophagy. | Q47693729 | ||
High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics. | Q47758619 | ||
Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis. | Q48126015 | ||
Correction: Symmetry: Modeling the Effects of Masking Noise, Axial Cueing and Salience. | Q49279492 | ||
Amyloid-β induced astrocytosis and astrocyte death: Implication of FoxO3a-Bim-caspase3 death signaling | Q50249558 | ||
Evaluation of the Expression of Amyloid Precursor Protein and the Ratio of Secreted Amyloid Beta 42 to Amyloid Beta 40 in SH-SY5Y Cells Stably Transfected with Wild-Type, Single-Mutant and Double-Mutant Forms of the APP Gene for the Study of Alzheim | Q51052529 | ||
Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. | Q51908453 | ||
LncRNA UCA1 impacts cell proliferation, invasion, and migration of pancreatic cancer through regulating miR-96/FOXO3. | Q52676183 | ||
Neuroblastoma | Q54265665 | ||
Pannexin-1 is involved in neuronal apoptosis and degeneration in experimental intracerebral hemorrhage in rats. | Q55338852 | ||
FOXO and FOXM1 in Cancer: The FOXO-FOXM1 Axis Shapes the Outcome of Cancer Chemotherapy | Q59102088 | ||
FoxO3a changes in pyramidal neurons and expresses in non-pyramidal neurons and astrocytes in the gerbil hippocampal CA1 region after transient cerebral ischemia | Q82468449 | ||
Monitoring 14-3-3 protein interactions with a homogeneous fluorescence polarization assay | Q83338029 | ||
Spectroscopic analysis on structure-affinity relationship in the interactions of different oleanane-type triterpenoids with bovine serum albumin | Q86065627 | ||
P433 | issue | 5 | |
P921 | main subject | neuroblastoma | Q938205 |
P304 | page(s) | 1080-1097 | |
P577 | publication date | 2019-10-07 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma | |
P478 | volume | 39 |
Q98939496 | Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancer |
Q83225642 | Modulating FOXO3 transcriptional activity by small, DBD-binding molecules |
Q92152691 | Repaglinide Silences the FOXO3/Lumican Axis and Represses the Associated Metastatic Potential of Neuronal Cancer Cells |
Q89776510 | Targeting DNA binding proteins for cancer therapy |
Q101564352 | Therapeutic strategies targeting FOXO transcription factors |